Evolution of the Average Target: AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

edcbd532e363900d4.MPsYvZ1WwoyDEsg8v8lFx9qWyUL1RSIjBgntXxdHI4A.W8h6ifAvp_XWQ5pS260X8O7x-QC-aBERdGqAG08uGsxeo2yL12WvucFghQ~ed211de735099c52b7b81da5a12189d5
09/09 RBC Capital Markets Initiates AstraZeneca Coverage at Outperform MT
09/09 RBC Initiates AstraZeneca at Outperform With GBP145 Price Target MT
09/09 RBC prefers Astra to GSK; HSBC cuts Burberry AN
09/09 RBC Initiates AstraZeneca at Outperform as Near-term Overhangs Create 'Attractive' Entry Point MT
09/09 AstraZeneca PLC : Gets a Buy rating from RBC ZD
09/09 AstraZeneca PLC : Buy rating from JP Morgan ZD
08/09 AstraZeneca PLC : Receives a Sell rating from Deutsche Bank ZD
08/09 Jefferies raises Autotrader and Rightmove AN
08/09 AstraZeneca PLC : Barclays maintains a Buy rating ZD
07/09 BofA Upbeat on AstraZeneca's Camizestrant After US Approval Based on Serena-6 Trial Results MT
07/09 AstraZeneca PLC : Gets a Buy rating from JP Morgan ZD
07/09 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
04/09 AstraZeneca: Share price weakness of late, should be capitalised on Alphavalue
03/09 AstraZeneca Kept at Buy as Berenberg Notes Upcoming COPD Data Readout MT
02/09 AstraZeneca PLC : Deutsche Bank reiterates its Sell rating ZD
01/09 AstraZeneca PLC : JP Morgan reaffirms its Buy rating ZD
28/08 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
25/08 AstraZeneca PLC : Gets a Sell rating from Deutsche Bank ZD
24/08 JPMorgan raises Diploma, Barclays cuts Unite AN
20/08 Cancer vaccines finally garner the spotlight Alphavalue
20/08 Goldman likes Astra; JPMorgan lowers Trainline AN
20/08 AstraZeneca PLC : Goldman Sachs reaffirms its Buy rating ZD
19/08 AstraZeneca PLC : Deutsche Bank reiterates its Sell rating ZD
19/08 AstraZeneca PLC : UBS reiterates its Buy rating ZD
17/08 BofA Notes AstraZeneca's Volrustomig Late-stage Study Fail; Buy Maintained MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+17.02%
+3.71%
+10.32%
+7.48%
+11.26%
+34.37%
-0.65%
+7.36%
+8.07%
Average +10.99%
Weighted average by Cap. +11.54%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
157.80USD
Average target price
212.04USD
Spread / Average Target
+34.37%
High Price Target
271.18USD
Spread / Highest target
+71.85%
Low Price Target
151.95USD
Spread / Lowest Target
-3.71%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!